Elidel’s Claim on Its Better Efficacy over Protopic Now Challenged

Published: 2004-12-27 06:58:00

Updated: 2004-12-27 06:58:00

In response to a recent announcement by Novartis on citing the favorable results for its Elidel (pimecrolimus) Cream 1% over Protopic (tacrolimus) Ointment 0.03%, a counter statement was recently made by the maker of Protopic.

Elidel’s claim on its advantages over Protopic were based on recent...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK